Stay updated with the latest injection-medicine news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on injection-medicine topics.
Mumbai/Naples: Lupin has taken a step forward in expanding its U.S. generics portfolio, securing regulatory progress for a key injectable product used in surgical care. Lupin has received tentative approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Sugammadex Injection. The approval covers two dosage strengths -- 200 mg/2 mL and 500 mg/5 mL -- both in single-dose vial formats. The company's product has been deemed bioequivalent to Merck's Bridion i ...Read More >
Bengaluru: Bangalore are you tired of trying viral trends and 'magic remedies' from social media to reduce weight? Today's youth want to be healthy, but a lack of correct information often leads them down the wrong path. Obesity is a complex medical condition that cannot be solved by a two-day diet or a viral challenge. What one needs is a scientific and reliable approach. The good news is that modern science now has a solution - called GLP1 RA (glucagon-like-peptide receptor agonist). This is a ...Read More >
New Delhi, Oct 9 (PTI) Drug firm Lupin on Thursday announced the launch of a strategic partnership programme aimed at expanding the reach of a long-acting injectable platform developed by its subsidiary, Nanomi BV. The platform, PrecisionSphere demonstrates efficacy and safety in drug delivery and is ready for commercial use, following the recent US Food and Drug Administration (USFDA) approval for the first product developed with this platform. The company's partnership programme is designed ...Read More >
MUMBAI, India and NAPLES, Fla., Oct. 9, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of a strategic partnership program aimed at expanding the reach of PrecisionSphere™ - the long-acting injectable (LAI) platform developed by its subsidiary, Nanomi B.V. (Nanomi). PrecisionSphere™ demonstrates efficacy and safety in drug delivery and is ready for commercial use, following the recent Unit ...Read More >
New Delhi [India], September 30 (ANI): The Central Drugs Standard Control Organisation (CDSCO) has approved Danish drugmaker Novo Nordisk's once-a-week injection for patients suffering from Type 2 diabetes. Also Read | Durga Puja 2025: PM Narendra Modi Participates in Durga Puja Celebrations in Delhi's CR Park on Occasion of Maha Ashtami, Prays for Everyone's Happiness and Wellbeing (See Pics). In a statement provided to ANI, Novo Nordisk has stated that Ozempic is intended for individuals wit ...Read More >
New Delhi [India], September 26 (ANI): European countries are expected to face the most immediate and severe impact from the new U.S. tariffs on imported branded or patented pharmaceutical products, while India may remain less affected for now, according to a press release by the Global Trade Research Initiative (GTRI). On Friday, U.S. President Donald Trump announced that from October 1, a 100 per cent tariff would be imposed on all imported branded or patented pharmaceutical products, unless ...Read More >
MUMBAI, Sept 25 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to bring its experimental oral weight-loss drug orforglipron to India as it sees market potential in the world's most populous nation, a senior executive said on Thursday. "I do think there is promise for products like that (orforpligron) in India, if it does get approved," Winselow Tucker, Lilly India's president said at an event in Mumbai. Tucker, however, did not indicate when Lilly plans to launch the drug. The drugmaker h ...Read More >
New Delhi [India], August 22 (ANI): India drug regulator has alerted on the theft of multiple drug products of Novo Nordisk during transit. According to the notice issued by the Drugs Controller General of India (DCGI), Dr Rajeev Raghuvanshi, Mis Novo Nordisk has informed about a theft of its products, as mentioned below, during transit from its Bhiwandi Hub to milk route (Nagpur, Raipur, Cuttack, and Kolkata). The DCGI has also mentioned in the notice that the quality of the injectables is re ...Read More >
Pithoragarh (Uttarakhand) [India], July 15 (ANI): Eight people were killed after a vehicle carrying 13 passengers met with an accident near the Suni bridge in Muwani town of Uttarakhand Pithoragarh district, a police officer said on Tuesday. Pithoragarh Superintendent of Police (SP) Rekha Yadav confirmed the incident and stated that a rescue operation is currently underway. Eight people died after a vehicle carrying 13 people crashed near the Suni bridge in Muwani town. The police officials ha ...Read More >
Hyderabad, July 15 (Maxim News): In a major boost for global healthcare access, Hyderabad-based Aurobindo Pharma has announced that it will manufacture and distribute the long-acting injectable HIV treatment drug, cabotegravir (CAB LA), across 133 countries. The development comes under an expanded voluntary licensing agreement between the Medicines Patent Pool (MPP) and ViiV Healthcare. This strategic agreement will allow Aurobindo to supply CAB LA for both prevention and treatment of HIV, offe ...Read More >
Bengaluru: Alembic Pharmaceuticals, Inc., the U.S. subsidiary of Alembic Pharmaceuticals Ltd., has acquired Utility Therapeutics Ltd. ("Utility") in a $12 million deal to strengthen its presence in the U.S. market. Alembic will begin the commercialization of Utility's recently FDA approved product Pivya® (pivmethecillam) for the treatment of uncomplicated urinary tract infections. Pivya® was approved by the FDA in April 2024. Commenting on the acquisition, Mr. Pranav Amin, Managing Director of ...Read More >
KOLKATA, India, Dec. 3, 2024 /PRNewswire/ -- Marking a transformative milestone in cardiac care, Manipal Hospitals, one of the largest healthcare networks in India announced the successful insertion of an AI-driven, wireless injectable pacemaker. The Aveir Leadless pacemaker by Abbott, recently introduced in India, was implanted in a 65-year-old woman at Manipal Hospital, Dhakuria, making it the first center in Eastern India to perform this procedure. The device, already in use in the US and Eur ...Read More >
Kolkata (West Bengal) [India], December 3: Marking a transformative milestone in cardiac care, Manipal Hospitals, one of the largest healthcare networks in India announced the successful insertion of an AI-driven, wireless injectable pacemaker. The Aveir Leadless pacemaker by Abbott, recently introduced in India, was implanted in a 65-year-old woman at Manipal Hospital, Dhakuria, making it the first center in Eastern India to perform this procedure. The device, already in use in the US and Europ ...Read More >
Novo Nordisk's team in India has been pushing the Danish drugmaker's global leadership for an earlier launch of its popular weight-loss drug Wegovy over fears of falling behind rival Eli Lilly in the potentially huge market, two sources familiar with the plans told Reuters. Officials at the Danish drugmaker have said Wegovy might be introduced in India in 2026 once regulatory approvals are in hand and there is sufficient supply. More recently, Novo's India team proposed moving the launch to nex ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.